M&A / Deals Arna Pharma and Slate Run complete JV for new US company Pharmaceutical TechnologyArna Pharma and Slate Run Pharmaceuticals have completed a JV to form a company focusing on branded products and 505(b)(2) medicines.Read full story pharminent May 15, 2026 Pharmaceutical Technology Arna Pharma and Slate Run Pharmaceuticals have completed a JV to form a company focusing on branded products and 505(b)(2) medicines. Read full story Post navigation Previous: Lilly UK recruits ex-England cricketer as obesity championNext: FDA approves Enhertu for two HER2-positive early breast cancer indications Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026